TP53 and mantle cell lymphoma: Recently, c-myelocytomatosis oncogene product (c-MYC) and tumor protein 53 (TP53) gene rearrangement were reported to be associated with aggressive biological behavior and overall inferior survival in a subgroup of MCL subjects for which, further in-depth studies are necessary [7,8].